Citations

Clear

20 citation(s) found for "Olson, Lyle".

The Effect of Diuresis on Extravascular Lung Water and Pulmonary Function in Acute Decompensated Heart Failure
Chase, Steven C. , Fermoyle, Caitlin C. , Wheatley, Courtney M. , Schaefer, Jacob J. , Olson, Lyle J. , Johnson, Bruce D.

Mayo Clinic

ESC Heart Failure | January 18, 2018 | Volume: 5 | Issue: 2 | Pages: 364-371

10.1002/ehf2.12253 | PMID 29345431 Get It

Abstract Aims The effect of extravascular lung water (EVLW) and relationship to functional status as a result of acute decompensated heart failure (ADHF) are not well understood. We sought to quantify changes in clinical variables, EVLW, airway anatomy, spirometry, and diffusing capacity for carbon monoxide before and after treatment for ADHF. Methods and results Fifteen patients were recruited within 24 h of hospital admission. Spirometry, diffusing capacity for carbon monoxide, and surrogates of EVLW by computed tomography were measured and were then repeated within 24 h of discharge. From the computed tomography (CT) scan, surrogates of EVLW were calculated from the distribution of CT attenuation of the lung tissue. Airways were segmented using the Vida Apollo software. Patients were hospitalized for 4.6 ± 2.1 days, had 10 ± 4.8 L of fluid removed (7.0 ± 4.2 L between study visits), and lost 7.1 ± 4.9 kg. Patients had significant clearance of fluid from the lungs (per cent change: mean, 4.2 ± 6.1%; skew, 17.5 ± 27.0%; kurtosis, 37.6 ± 56.7%; full-width half-maximum, 10.2 ± 13.5%). Static lung volumes and maximal flows improved significantly (per cent change: forced vital capacity, 14.5 ± 13.6%; forced expiratory volume in 1 s, 15.9 ± 14.0%; forced expiratory flow at 25–75% of forced vital capacity, 27.2 ± 42.9%). The ratio of membrane conductance to capillary blood volume improved significantly (per cent change: alveolar–capillary membrane conductance/capillary blood volume, 23.4 ± 22.8%). Weight loss during hospitalization was significantly correlated with improved spirometry and diffusing capacity. Conclusions Extravascular lung water contributes to the pulmonary congestive syndrome in ADHF patients, and its clearance is an important component of the improvement in pulmonary function as a result of inpatient treatment.
Low leptin concentration may identify heart failure patients with central sleep apnea
Čundrle, Ivan , Singh, Prachi , Johnson, Bruce D. , Olson, Lyle J. , Olson, Lyle J , Somers, Virend K. , Scott, Christopher G. , Singh, Prachi , Cundrle, Ivan

Mayo Clinic

Journal of Sleep Research | June 23, 2017 | Volume: 27 | Issue: 2 | Pages: 240-243

10.1111/jsr.12574 | PMID 28643476 Get It

SummaryLow leptin concentration has been shown to be associated with central sleep apnea in heart failure patients. We hypothesized that low leptin concentration predicts central sleep apnea. Consecutive ambulatory New York Heart Association (NYHA) classes I–IV heart failure patients were studied prospectively, including measurement of serum leptin, echocardiography and polysomnography. Sleep apnea was defined by type (central/mixed/obstructive) and by apnea–hypopnea index ≥5 by polysomnography. Subjects were divided into four groups by polysomnography: (1) central sleep apnea, (2) mixed apnea, (3) no apnea and (4) obstructive sleep apnea. Fifty‐six subjects were included. Eighteen subjects were diagnosed with central sleep apnea, 15 with mixed apnea, 12 with obstructive apnea and 11 with no sleep apnea. Leptin concentration was significantly lower in central sleep apnea compared to obstructive apnea (8 ± 10.7 ng mL−1 versus 19.7 ± 14.7 ng mL−1, P ˂ 0.01) or no sleep apnea (8 ± 10.7 ng mL−1 versus 17.1 ± 8.4 ng mL−1, P ˂ 0.01). Logistic regression showed leptin to be associated independently with central sleep apnea [odds ratio (OR): 0.19; 95% confidence interval (CI): 0.06–0.62; area under the curve (AUC): 0.80, P < 0.01]. For the detection of central sleep apnea, a cut‐off value for leptin concentration 5 ng mL−1 yielded a sensitivity of 50% and specificity of 89%. In conclusion, a low leptin concentration may have utility for the screening of heart failure patients for central sleep apnea.
Impact of chronic systolic heart failure on lung structure-function relationships in large airways
Chase, Steven C. , Wheatley, Courtney M. , Olson, Lyle J. , Beck, Kenneth C., Wentz, Robert J., Snyder, Eric M., Taylor, Bryan J. , Johnson, Bruce D. , Taylor, Bryan J

Mayo Clinic

Physiological Reports | July 14, 2016 | Volume: 4 | Issue: 13 | Pages: e12867

10.14814/phy2.12867 | PMID 27418546 Get It

Histologic and Cytokine Response to Immunosuppression in Giant-Cell Myocarditis
Levy, Nat T., Olson, Lyle J., Weyand, Cornelia, Brack, Alexander, Tazelaar, Henry D., Edwards, William D., Hammill, Stephen C., Olson, Lyle J., Weyand, Cornelia, Brack, Alexander, Tazelaar, Henry D., Edwards, William D., Hammill, Stephen C.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 128 | Issue: 8 | Pages: 648-650

10.7326/0003-4819-128-8-199804150-00007 | PMID 9537938 Get It

Left Ventricular Discoordination Index Measured by Speckle Tracking Strain Rate Imaging Predicts Reverse Remodelling and Survival After Cardiac Resynchronization Therapy
Wang, Chun‐Li, Powell, Brian D. , Redfield, Margaret M. , Miyazaki, Chinami , Olson, Lyle J. , Cha, Yong‐Mei , Espinosa, Raúl E. , Hayes, David L. , Hodge, David O. , Lin, Grace , Friedman, Paul A. , Oh, Jae K. , Fine, Nowell Mark

Mayo Clinic

European Journal of Heart Failure | March 12, 2012 | Volume: 14 | Issue: 5 | Pages: 517-525

10.1093/eurjhf/hfs025 | PMID 22411692 Get It

Abstract Aims This study aimed to evaluate the predictive value of a baseline speckle tracking strain rate imaging-derived discoordination index for response to cardiac resynchronization therapy (CRT). Methods and results Ninety-seven patients with QRS ≥120 ms and left ventricular (LV) ejection fraction ≤35% were prospectively followed after CRT in the Mayo CRT Registry. The LV discoordination index (stretch/shortening or thinning/thickening during ejection) was calculated from three types of deformation, radial, circumferential, and longitudinal, using two-dimensional speckle tracking strain rate imaging. The benefit of CRT was evaluated by reverse remodelling (i.e. reduction of LV end-systolic volume ≥15% at 6-month follow-up) and survival. The optimal cut-off value of the baseline discoordination index in discriminating responders from non-responders was determined by receiver operating characteristic curve analysis. Significant differences in baseline indices between responders and non-responders were noted for radial and circumferential discoordination indices. A mid-ventricular radial discoordination index (RDI-M) &gt;38% best predicted responders, especially in patients with ischaemic cardiomyopathy (area under the curve 0.86 for all patients, sensitivity 80%, and specificity 91%). Death occurred in 28 patients over a median follow-up of 3.2 years. When adjusted for confounding variables, lack of significant discoordination (RDI-M &lt;38%) before CRT was associated with a particularly high mortality (hazard ratio 7.05, 95% confidence interval 2.45–26.0). Conclusion LV discoordination assessed by speckle tracking RDI-M imaging was able to predict reverse remodelling at 6 months and survival of patients who received CRT.
Dyssynchrony Indices To Predict Response to Cardiac Resynchronization Therapy
Miyazaki, Chinami , Redfield, Margaret M. , Powell, Brian D. , Lin, Grace, Herges, Regina M., Hodge, David O. , Olson, Lyle J. , Hayes, David L. , Espinosa, Raúl E. , Rea, Robert F., Nelson, Susan M., Miller, Fletcher A., Oh, Jae K. , Bruce, Charles J.

Mayo Clinic

Circulation: Heart Failure | July 21, 2010 | Volume: 3 | Issue: 5 | Pages: 565-573

10.1161/circheartfailure.108.848085 | PMID 20647479 Get It

Background— Whether mechanical dyssynchrony indices predict reverse remodeling (RR) or clinical response to cardiac resynchronization therapy (CRT) remains controversial. This prospective study evaluated whether echocardiographic dyssynchrony indices predict RR or clinical response after CRT. Methods and Results— Of 184 patients with heart failure with anticipated CRT who were prospectively enrolled, 131 with wide QRS and left ventricular ejection fraction <35% had 6-month follow-up after CRT implantation. Fourteen dyssynchrony indices (feasibility) by M-mode (94%), tissue velocity (96%), tissue Doppler strain (92%), 2D speckle strain (65% to 86%), 3D echocardiography (79%), and timing intervals (98%) were evaluated. RR (end-systolic volume reduction ≥15%) occurred in 55% and more frequently in patients without (71%) than in patients with (42%) ischemic cardiomyopathy ( P =0.002). Overall, only M-mode, tissue Doppler strain, and total isovolumic time had a receiver operating characteristic area under the curve (AUC) greater than the line of no information, but none of these were strongly predictive of RR (AUC, 0.63 to 0.71). In nonischemic cardiomyopathy, no dyssynchrony index predicted RR. In ischemic cardiomyopathy, M-mode (AUC, 0.67), tissue Doppler strain (AUC, 0.79), and isovolumic time (AUC, 0.76) -derived indices predicted RR ( P <0.05 for all), although the incremental value was modest. No indices predicted clinical response assessed by Minnesota Living with Heart Failure Questionnaire, 6-minute walk distance, and peak oxygen consumption. Conclusions— These findings are consistent with the Predictors of Response to CRT study and do not support use of these dyssynchrony indices to guide use of CRT.
Advanced Heart Failure and Nocturnal Hypoxaemia Due to Central Sleep Apnoea are Associated with Increased Serum Erythropoietin
Calvin, Andrew D. , Steensma, David P. , Pérez, José A., Walt, Christelle van der, Fitz‐Gibbon, Jennifer M., Scott, Christopher G. , Olson, Lyle J. , Somers, Virend K. , Scott, Christopher , Steensma, David P , Calvin, Andrew D

Mayo Clinic

European Journal of Heart Failure | March 24, 2010 | Volume: 12 | Issue: 4 | Pages: 354-359

10.1093/eurjhf/hfq005 | PMID 20335353 Get It

Abstract Aims Central sleep apnoea (CSA) and increased serum erythropoietin (EPO) concentration have each been associated with adverse prognosis in heart failure (HF) patients. The aim of this study was to examine the relationship between nocturnal hypoxaemia due to CSA and the serum EPO concentration in patients with HF. Methods and results Heart failure subjects (n = 33) and healthy controls (n = 18) underwent polysomnography (PSG) for diagnosis of CSA and identification and quantification of hypoxaemia. Blood collection for measurement of EPO was performed immediately post-PSG. For the analysis, HF subjects were dichotomized into subgroups defined by the presence or absence of CSA and by HF severity. Multivariate analyses were performed to evaluate the relationships of hypoxaemia and advanced HF to EPO concentration. Mean EPO concentration was 62% higher for HF subjects with CSA than for healthy controls (P = 0.004). The magnitude of nocturnal hypoxaemia was significantly and positively related to EPO concentration (r = 0.45, P = 0.02). Advanced HF was also significantly and positively related to EPO concentration (r = 0.43, P = 0.02). On multivariate analysis, the presence of combined nocturnal hypoxaemia and advanced HF yielded greater correlation to EPO concentration than either factor alone (r = 0.57, P = 0.04 and P = 0.05, respectively). Linear regression demonstrated that the combination of New York Heart Association Class and CSA was strongly associated with EPO concentration (P &lt; 0.0001). Conclusion In non-anaemic HF patients, advanced HF and hypoxaemia due to CSA may each be independently associated with increased serum EPO concentration.
Cardiac Resynchronization by Restoration of Native Ventricular Activation
Sagar, Sandeep , Espinosa, Raúl E. , Louwagie, Curtis R., Olson, Lyle J. , Jahangir, Arshad

Mayo Clinic

Circulation | April 22, 2008 | Volume: 117 | Issue: 16 | Pages: 2160-2161

10.1161/circulationaha.107.718650 | PMID 18427146 Get It

Treating Central Sleep Apnea in Heart Failure
Olson, Lyle J. , Somers, Virend K.

Mayo Clinic

Circulation | June 25, 2007 | Volume: 115 | Issue: 25 | Pages: 3140-3142

10.1161/circulationaha.107.709303 | PMID 17592088 Get It

Angiotensin-Converting Enzyme Genotype Modulates Pulmonary Function and Exercise Capacity in Treated Patients With Congestive Stable Heart Failure
Abraham, M. Roselle , Olson, Lyle J. , Joyner, Michael J. , Beck, Ken C., Johnson, Bruce D. , Turner, Stephen T. , Joyner, Michael J

Mayo Clinic

Circulation | September 30, 2002 | Volume: 106 | Issue: 14 | Pages: 1794-1799

10.1161/01.cir.0000031735.86021.79 | PMID 12356632 Get It

Background— The gene encoding ACE exhibits an insertion/deletion polymorphism resulting in 3 genotypes (DD, ID, and II), which affects serum and tissue ACE activity as well as other vasoactive substances. Pulmonary function is frequently abnormal in patients with congestive heart failure (CHF), the mechanism of which has not been completely characterized. ACE inhibition has been shown to improve diffusion across the alveolar-capillary membrane and to improve exercise capacity and gas exchange in CHF. The aim of the current study was to determine if ACE genotype is associated with altered pulmonary function and exercise intolerance in patients with treated CHF. Methods and Results— Fifty-seven patients (stratified according to ACE genotype as17 DD, 28 ID, 12 II) with ischemic and dilated cardiomyopathy, left ventricular ejection fraction (LVEF) <35%, and <10 pack-years of smoking history were studied. All patients were receiving standard therapy for left ventricular systolic dysfunction. Pulmonary function, LVEF, serum ACE, plasma angiotensin II, atrial natriuretic peptide, and brain natriuretic peptide were measured at baseline. Peak V̇ o 2 and gas exchange measurements were assessed with graded exercise. Resting LVEF was similar among the genotype groups (25% to 28%), and no differences were observed in diastolic function or pulmonary artery pressures ( P >0.05). Mean peak V̇ o 2 and forced vital capacity (% Pred) were significantly reduced ( P <0.05), whereas mean serum ACE activity and plasma angiotensin II concentration were highest in DD homozygotes. Subjects homozygous for the D-allele also demonstrated higher mean ventilatory equivalents for carbon dioxide (V̇ e /V̇ co 2 ) during exercise ( P <0.05). Conclusions— ACE DD genotype is associated with decreased exercise tolerance in CHF, possibly mediated by altered pulmonary function. Pharmacological strategies effecting more complete inhibition of serum and tissue ACE and/or potentiation of bradykinin may improve exercise capacity in patients with CHF and ACE DD genotype.